BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem

Reuters10-29

Oct 29 (Reuters) - NLS Pharmaceutics AG NLSP.O:

NLS PHARMACEUTICS LTD. ANNOUNCES 1-FOR-10 REVERSE SHARE SPLIT AND NAME CHANGE IN CONNECTION WITH PROPOSED MERGER WITH KADIMASTEM
NLS PHARMACEUTICS - REVERSE SPLIT EFFECTIVE IN SWITZERLAND ON OCTOBER 30, 2025
NLS PHARMACEUTICS - COMMON SHARES TO TRADE ON NASDAQ AS NCEL UNDER NEW NAME NEWCELX LTD

Source text: ID:nPn5W1RwGa

Further company coverage: NLSP.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579622975?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-29 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579622975","market":"nz","top_or_hot":-1,"title":"BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem</title></head><body><p><span>Oct 29 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/NLSP\">NLS Pharmaceutics</a> AG <span>NLSP.O</span>:</p><ul><li><p>NLS PHARMACEUTICS LTD. ANNOUNCES 1-FOR-10 REVERSE SHARE SPLIT AND NAME CHANGE IN CONNECTION WITH PROPOSED MERGER WITH KADIMASTEM</p></li><li><p>NLS PHARMACEUTICS - REVERSE SPLIT EFFECTIVE IN SWITZERLAND ON OCTOBER 30, 2025</p></li><li><p>NLS PHARMACEUTICS - COMMON SHARES TO TRADE ON NASDAQ AS NCEL UNDER NEW NAME NEWCELX LTD</p></li></ul><p>Source text: <span>ID:nPn5W1RwGa</span></p><p>Further company coverage: <span>NLSP.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-29 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With Kadimastem</title></head><body><p><span>Oct 29 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/NLSP\">NLS Pharmaceutics</a> AG <span>NLSP.O</span>:</p><ul><li><p>NLS PHARMACEUTICS LTD. ANNOUNCES 1-FOR-10 REVERSE SHARE SPLIT AND NAME CHANGE IN CONNECTION WITH PROPOSED MERGER WITH KADIMASTEM</p></li><li><p>NLS PHARMACEUTICS - REVERSE SPLIT EFFECTIVE IN SWITZERLAND ON OCTOBER 30, 2025</p></li><li><p>NLS PHARMACEUTICS - COMMON SHARES TO TRADE ON NASDAQ AS NCEL UNDER NEW NAME NEWCELX LTD</p></li></ul><p>Source text: <span>ID:nPn5W1RwGa</span></p><p>Further company coverage: <span>NLSP.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NCEL","symbol_name":"NewcelX Ltd.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA98VMQY:1","article_id":"2579622975","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579622975","pubTimestamp":1761732392,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With KadimastemOct 29 (Reuters) - NLS Pharmaceutics AG NLSP.O:NLS PHARMACEUTICS LTD. A","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NCEL":"NewcelX Ltd.","NLSP":"NLS Pharmaceutics Ltd.","NLSPW":"NLS Pharmaceutics Ltd. Warrant","BK4007":"制药"},"translate_title":"简报-Nls Pharmaceutics宣布与Kadimastem拟议合并进行10股1反向股份分割和更名","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NLSPW":0.9,"NLSP":0.9,"NCEL":0.9},"content_text":"BRIEF-Nls Pharmaceutics Announces 1-for-10 Reverse Share Split And Name Change In Connection With Proposed Merger With KadimastemOct 29 (Reuters) - NLS Pharmaceutics AG NLSP.O:NLS PHARMACEUTICS LTD. ANNOUNCES 1-FOR-10 REVERSE SHARE SPLIT AND NAME CHANGE IN CONNECTION WITH PROPOSED MERGER WITH KADIMASTEMNLS PHARMACEUTICS - REVERSE SPLIT EFFECTIVE IN SWITZERLAND ON OCTOBER 30, 2025NLS PHARMACEUTICS - COMMON SHARES TO TRADE ON NASDAQ AS NCEL UNDER NEW NAME NEWCELX LTDSource text: ID:nPn5W1RwGaFurther company coverage: NLSP.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579622975","isCrawlerRequest":true}